Zostavax
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
148 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Herpes zoster | D006562 | EFO_0006510 | B02 | 24 | 24 | 45 | 21 | 16 | 124 |
| Herpes simplex | D006561 | — | B00 | 10 | 10 | 24 | 2 | 4 | 48 |
| Chickenpox | D002644 | EFO_0007204 | B01 | 5 | 4 | 3 | 4 | 2 | 17 |
| Arthritis | D001168 | HP_0001369 | M05-M14 | 1 | 3 | — | 2 | — | 6 |
| Varicella zoster virus infection | D000073618 | — | — | 3 | 1 | 2 | 1 | — | 6 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | 3 | — | 1 | — | 5 |
| Healthy volunteers/patients | — | — | — | — | 1 | 1 | 2 | 1 | 5 |
| Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 1 | — | — | 2 | 2 | 5 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | 3 | — | 3 |
| Rheumatic diseases | D012216 | — | M79.0 | — | — | — | 3 | — | 3 |
Show 35 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vaccine-preventable diseases | D000079263 | — | — | 4 | 1 | 1 | — | 1 | 6 |
| Virus diseases | D014777 | — | B34 | 1 | — | 1 | — | 1 | 3 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | — | 1 | 1 | — | — | 2 |
| Pneumococcal infections | D011008 | EFO_0000772 | J13 | — | — | 1 | — | — | 1 |
| Hematologic neoplasms | D019337 | — | — | — | — | 1 | — | — | 1 |
| Neuralgia | D009437 | EFO_0009430 | — | — | — | 1 | — | — | 1 |
| Postherpetic neuralgia | D051474 | — | — | — | — | 1 | — | — | 1 |
| Dementia | D003704 | EFO_0003862 | F03 | — | — | 1 | — | — | 1 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | 1 | — | — | 1 |
| Respiratory syncytial virus infections | D018357 | EFO_1001413 | — | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 1 | 1 | — | — | 1 | 3 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 1 | — | — | 1 | 3 |
| Lymphoid leukemia | D007945 | — | C91 | 1 | 1 | — | — | 1 | 3 |
| Infections | D007239 | EFO_0000544 | — | 2 | 1 | — | — | — | 3 |
| Communicable diseases | D003141 | — | — | 1 | 1 | — | — | — | 2 |
| Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
| Stem cell transplantation | D033581 | — | — | — | 1 | — | — | — | 1 |
| Bone marrow transplantation | D016026 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | — | 1 |
| Osteosarcoma | D012516 | — | — | 1 | — | — | — | — | 1 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | 1 | — | — | — | — | 1 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | 1 | — | — | — | — | 1 |
| Immunosenescence | D000068884 | — | — | 1 | — | — | — | — | 1 |
| Waldenstrom macroglobulinemia | D008258 | HP_0005508 | C88.0 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
| Immunologic deficiency syndromes | D007153 | HP_0002721 | D84.9 | — | — | — | — | 1 | 1 |
| Agammaglobulinemia | D000361 | HP_0004313 | D80.1 | — | — | — | — | 1 | 1 |
| Common variable immunodeficiency | D017074 | EFO_0000367 | D83 | — | — | — | — | 1 | 1 |
| Hepatitis c | D006526 | — | B19.2 | — | — | — | — | 1 | 1 |
| Yellow fever | D015004 | — | A95 | — | — | — | — | 1 | 1 |
| Immune system diseases | D007154 | — | D89.9 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Zostavax – Merck & Co
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use